CollPlant Biotechnologies Ltd.

CLGNNASDAQHealthcare● Active

$0.37

+$0.00(+0.46%)

Market Cap$4542787

P/E Ratio—

52W High$3.232

52W Low$0.271

Avg Volume81K

Open$0.37

Beta0.64

Overview

Foreign Private Issuer · Files 20-F / 6-K

CollPlant Biotechnologies Ltd. (CLGN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001631487 · CLGN · NASDAQ · as of Jun 9, 2026

Filing snapshot

318

Total Filings

6-K

Latest Form

2026-05-29

Most Recent

2018

Filing Since

Financials Earnings View All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001631487 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY

Filed Date

2026-03-26

Fiscal Year End

Mar 26, 2026

Accession No.

0001213900-26-034393

Primary Document

ea0282912-20f_collplant.htm

View on SEC EDGAR Download PDF Filing Index

Source: data.sec.gov · CIK 0001631487 · Accession 0001213900-26-034393

Latest Key Filings

6-KQuarterly Report

REPORT OF FOREIGN PRIVATE ISSUER

2026-05-29

View 6-K on SEC

8-KCurrent Report

No recent filings

Form 4Insider Activity

Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144

Filed Date

Form Type

Description

View

2026-05-29

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-062423

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-05-29

View

2026-04-27

Initial Statement of Beneficial Ownership

0001213900-26-047993

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-04-27

View

2026-04-21

EFFECT

9999999995-26-001268

View

EFFECTEFFECT

EFFECT

2026-04-21

View

2026-04-21

424B3

PROSPECTUS

0001213900-26-046237

View

424B3424B3

PROSPECTUS

2026-04-21

View

2026-04-17

CORRESP

0001213900-26-045150

View

CORRESPCORRESP

CORRESP

2026-04-17

View

2026-04-15

F-1/A

PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1

0001213900-26-044069

View

F-1/AF-1/A

PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1

2026-04-15

View

2026-04-13

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-042773

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-04-13

View

2026-04-01

UPLOAD

0000000000-26-003285

View

UPLOADUPLOAD

UPLOAD

2026-04-01

View

2026-03-30

F-1

REGISTRATION STATEMENT

0001213900-26-036445

View

F-1F-1

REGISTRATION STATEMENT

2026-03-30

View

2026-03-26

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-034402

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-03-26

View

2026-03-26

20-F

Annual Report (Foreign Issuer)

ANNUAL REPORT

0001213900-26-034393

View

20-FAnnual Report (Foreign Issuer)

ANNUAL REPORT

2026-03-26

View

2026-03-24

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-26-033538

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2026-03-24

View

2026-03-19

Initial Statement of Beneficial Ownership

0001213900-26-031870

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-19

View

2026-03-18

Initial Statement of Beneficial Ownership

0001213900-26-030193

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

View

2026-03-18

Initial Statement of Beneficial Ownership

0001213900-26-030191

View

3Initial Statement of Beneficial Ownership

Initial Statement of Beneficial Ownership

2026-03-18

View

Showing 1–15 of 314 filingsForm 4 / 144 hidden· 318 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov) | Updated: Hourly | CIK: 0001631487 | Exchange: NASDAQ · Healthcare

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) has submitted 318 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001631487, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is CollPlant Biotechnologies Ltd.'s most comprehensive regulatory disclosure. The most recent CollPlant Biotechnologies Ltd. 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical CLGN 10-K annual reports are available from 2015 through 2026.

Investors researching CollPlant Biotechnologies Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Related Companies SEC Filings — Healthcare

RLYB SEC Filings →NRXS SEC Filings →KLTO SEC Filings →NRSN SEC Filings →XCUR SEC Filings →ENLV SEC Filings →TAOX SEC Filings →CVKD SEC Filings →

→ CLGN Financials → CLGN Earnings → CLGN Insider Trades

Frequently Asked Questions

CLGN SEC Filings · 8 questions

CollPlant Biotechnologies Ltd. (CLGN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 318 filings and access original documents at no cost. CollPlant Biotechnologies Ltd.'s CIK is 0001631487.

CLGN SEC filingsCollPlant Biotechnologies Ltd. SEC documentsfind CLGN 10-K